See the difference! Customize Seeking Alpha:
Sign in or join
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Adolor Corp. (ADLR)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: ADLR
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Top Authors
Most frequent coverage on ADLR
TickerSense
(135 followers)
Russell 3000's Best and Worst Stocks, Week and Year to Date
(Sat, Apr 14)
Russell 3000's Best and Worst Performing Stocks - 5 Days, 3 Months, YTD
(Mon, Nov 20)
Russell 3000's Best and Worst Performing Stocks
(Mon, Nov 13)
More by TickerSense on ADLR »
Centient Biotech Investor
(10 followers)
Biotech Day In Review: Entereg from GSK and Adolor Fails Test
(Wed, Apr 11)
Biotech Day in Review: Glaxo Gets Approval for Tykerb
(Wed, Mar 14)
Biotech Day In Review: Merger Monday
(Tue, Feb 13)
More by Centient Biotech Investor on ADLR »
BioBlogger
(3 followers)
Does Adolor’s Announcement of Positive Entereg Data Assure FDA Approval? (ADLR)
(Wed, Feb 8)
More by BioBlogger on ADLR »
Most followed authors on ADLR
Mike Havrilla
(1967 followers)
Looking for Laggards After the Latest Market Rally
(Tue, Dec 9)
More by Mike Havrilla on ADLR »
Michael Becker
(176 followers)
11 Ache-Free Investment Opportunities in Neuropathic Pain
(Wed, Sep 30)
More by Michael Becker on ADLR »
TickerSense
(135 followers)
Russell 3000's Best and Worst Stocks, Week and Year to Date
(Sat, Apr 14)
Russell 3000's Best and Worst Performing Stocks - 5 Days, 3 Months, YTD
(Mon, Nov 20)
Russell 3000's Best and Worst Performing Stocks
(Mon, Nov 13)
More by TickerSense on ADLR »
Newest authors on ADLR
Michael Becker
(176 followers)
11 Ache-Free Investment Opportunities in Neuropathic Pain
(Wed, Sep 30)
More by Michael Becker on ADLR »
David Greene
(6 followers)
Progenics: Are the Prospects That Bad?
(Mon, Nov 16)
More by David Greene on ADLR »
Mike Havrilla
(1967 followers)
Looking for Laggards After the Latest Market Rally
(Tue, Dec 9)
More by Mike Havrilla on ADLR »
Most commented on ADLR
Mike Havrilla
(1967 followers)
Looking for Laggards After the Latest Market Rally
(Tue, Dec 9)
More by Mike Havrilla on ADLR »
Michael Becker
(176 followers)
11 Ache-Free Investment Opportunities in Neuropathic Pain
(Wed, Sep 30)
More by Michael Becker on ADLR »